Bruce Cozadd, Co-Founder, Chairperson and CEO, Plans to Retire as CEO Upon Appointment of Successor by the End of 2025; Will Continue as Chair of the Board Mr. Cozadd Has Led Growth of Company from Founding to $4 Billion+ in 2024 Expected Total Revenue Board Will Lead Comprehensive...
Read More Details
Finally We wish PressBee provided you with enough information of ( Jazz Pharmaceuticals Announces CEO Succession Plan )
Also on site :
- Global March to Gaza activists report delays, deportations at Cairo Airport
- ‘She lit up the classroom’: First British victims of Air India plane crash named after 241 killed
- What nuclear sites does Iran have and where are they?